← Back to All Filings

Cintas Director Karen L. Carnahan Receives Annual Equity Grants & Phantom Stock

Low SignificanceOctober 29, 2026 at 6:08:04 PM EDT

CINTAS CORP

$CTAS4CIK: 0000723254

Subscribe to track CTAS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# Form 4: Cintas Corp (CTAS)
**Insider:** Karen L. Carnahan (Director)
**Filing Date:** October 29, 2026

### Non-Derivative Transactions
- **Common Stock (Grant):** 459 shares acquired at $0.00 (Cliff vests in 1 year)
- **Shares Held Post-Transaction:** 25,715 shares

### Derivative Transactions
- **Phantom Stock Units:** 133.85 units acquired at $214.80 (Elective fee deferral)
- **Stock Options:** 1,648 options acquired (Exercise Price: $212.81, Exp: 10/28/2036)

**Trading Significance:** Low (Routine Director Equity Compensation)

Comprehensive Analysis

Executive Summary

On October 29, 2026, Cintas Corporation ($CTAS) director Karen L. Carnahan filed a Form 4 disclosing routine director equity compensation grants and deferred compensation elections.

Transaction Breakdown

  1. Restricted Common Stock Grant (10/28/2026):

    • Shares Acquired: 459 shares granted under the 2016 Amended and Restated Equity and Incentive Compensation Plan.
    • Price: $0.00.
    • Vesting: Cliff vests on the first anniversary of the grant date.
    • Post-Transaction Holdings: 25,715 direct shares.
  2. Phantom Stock Units (10/27/2026):

    • Units Acquired: 133.85 phantom stock units acquired at $214.80 per unit pursuant to the Directors' Deferred Compensation Plan via deferred cash retainer fees.
    • Post-Transaction Holdings: 6,967.48 phantom stock units.
  3. Stock Options (10/28/2026):

    • Options Acquired: 1,648 stock options with an exercise price of $212.81 per share, expiring on October 28, 2036.
    • Vesting: Cliff vests on the first anniversary of the grant date.

Market & Governance Context

These transactions represent standard annual director compensation and routine fee deferrals. Because these are planned corporate grants and elective salary/fee deferrals rather than open-market purchases or sales, the market significance of this filing is categorized as Low.

Topics:#CTAS#Cintas#InsiderTrading#StockCompensation#Form4

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.